Glenmark Pharmaceuticals rises on inking pact with Canada’s Immanence IDC

16 Nov 2011 Evaluate

Glenmark Pharmaceuticals is currently trading at Rs 334.90, up by 0.60 points or 0.18% from its previous closing of Rs 334.30 on the BSE.

The scrip opened at Rs 333.80 and has touched a high and low of Rs 335.80 and Rs 333.55 respectively. So far 13442 shares were traded on the counter.

The BSE group 'A' stock of face value Rs 1 has touched a 52 week high of Rs 389.75 on 07-Dec-2010 and a 52 week low of Rs 241.60 on 28-Feb-2011.

Last one week high and low of the scrip stood at Rs 341.20 and Rs 311.25 respectively. The current market cap of the company is Rs 9039.90 crore.

The promoters holding in the company stood at 48.29% while Institutions and Non-Institutions held 39.02% and 12.69% respectively.

Glenmark Pharmaceuticals has signed a ten-year pact with Canada's Immanence IDC to sell dermatology products in eight countries, including India. Brazil, Mexico, South Africa, Egypt, Vietnam, Malaysia and Thailand are the other countries where the company will sell the products. By the end of FY12, Glenmark Pharmaceuticals plans to rollout the product in most of these countries.

Glenmark Pharmaceuticals, a leader among the emerging market companies in drug discovery and development and most of its active substances in the pipeline are first-in-Class. Glenmark’s achievements over the year include a major deal with Sanofi in Crohn's disease, completing Phase II trials of its first novel product, crofelemer and demonstrated higher sales and profit growth.

The company’s net profit for the quarter ended September 30, 2011 has increased 14.23% at Rs 31.46 crore as compared to Rs 27.54 crore for the corresponding quarter of the previous year. The company’s total income has surged 48.22% at Rs 383.67 crore for the second quarter of the current fiscal from Rs 258.86 crore for the corresponding quarter of the previous year.

Glenmark Pharma Share Price

1965.75 -8.40 (-0.43%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×